NCT06463132View on ClinicalTrials.gov

Phase 1b Clinical Trial to Evaluate PEP and EUFLEXXA for Knee Osteoarthritis (KOA)

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

November 1, 2024

Primary Completion Date

November 1, 2025

Study Completion Date

November 1, 2025

Conditions
Knee Osteoarthritis
Interventions
COMBINATION_PRODUCT

PEP/Euflexxa

Euflexxa (PMA: P010029)

DRUG

PEP

PEP (Purified Exosome Product)

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors
All Listed Sponsors
collaborator

Caidya Clinical Research Organization

UNKNOWN

lead

Rion Inc.

INDUSTRY